Comparative Efficacy and Safety Study of Three Different Doses of a Formulation Composed of Crystalline Estradiol and Progesterone Microspheres, Indicated for Monthly IM Injection for the Treatment ot Climacteric Symptoms.
Phase of Trial: Phase II/III
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Estradiol/progesterone (Primary)
- Indications Menopausal syndrome
- Focus Therapeutic Use
- 26 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Nov 2008 New trial record.